Cellectis (CLLS) Debt Ratio (2014 - 2026)
Cellectis' (CLLS) quarterly Debt Ratio came in at 0.26 in Q1 2026, up 41.83% year-on-year from 0.19 in Q1 2025, and up 1.56% quarter-over-quarter from 0.26 in Q4 2025.
Cellectis (CLLS) Debt Ratio (2014 - 2026) Analysis & Trends
Cellectis' Debt Ratio history runs 13 years deep, the most recent figure standing at 0.26 for Q1 2026.
- On a quarterly basis, Debt Ratio rose 41.83% year-over-year to 0.26 in Q1 2026; TTM through Mar 2026 was 0.26, a 41.83% increase from a year earlier, with the FY2025 full-year figure at 0.26, up 48.88% from the prior year.
- Debt Ratio rose to 0.26 in Q1 2026 per CLLS's latest filing, from 0.26 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.26 in Q1 2026 and bottomed at 0.08 in Q2 2022.
- The 5-year median for Debt Ratio is 0.17 (2024), against an average of 0.17.
- Across the five-year window, Debt Ratio soared 156.81% in 2023 and declined 26.61% in 2024, its largest moves.
- Year by year, Debt Ratio stood at 0.1 in 2022, then surged by 65.98% to 0.16 in 2023, then rose by 7.34% to 0.17 in 2024, then soared by 48.88% to 0.26 in 2025, then advanced by 1.56% to 0.26 in 2026.
- Per Business Quant, the three latest CLLS Debt Ratio figures stand at 0.26 (Q1 2026), 0.26 (Q4 2025), and 0.24 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | 0.26 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.19 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |